US2024016185A1PendingUtilityA1
Plant base/animal cell hybrid meat substitute
Est. expiryOct 19, 2041(~15.2 yrs left)· nominal 20-yr term from priority
A23J 3/227C12N 5/0658A23J 3/14A23J 3/04A23L 13/00
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Meat substitute recipes with animal cells and exogenous heme-containing protein on plant-based meat dough matrices are disclosed. Methods of producing are also disclosed.
Claims
exact text as granted — not AI-modified1 . A hybrid meat substitute product comprising:
a) at least 30% by weight plant-based meat dough; b) at least 1% by weight cultured animal cells; and c) at least 0.50% by weight exogenous heme-containing protein.
2 . The hybrid meat substitute product of claim 1 , comprising between 0.5-5% the exogenous heme-containing protein by weight.
3 . The hybrid meat substitute product of claim 1 , wherein the exogenous heme-containing protein is provided as a cell-free ingredient.
4 . The hybrid meat substitute product of claim 1 , wherein the exogenous heme-containing protein is a myoglobin.
5 . The hybrid meat substitute product of claim 4 , wherein at least 30% of the myoglobin is oxymyoglobin.
6 . The hybrid meat substitute product of claim 1 , comprising at least 0.0005% by weight of iron (Fe) bound to the exogenous heme-containing protein.
7 . The hybrid meat substitute product of claim 1 , comprising between 0.0005-0.02% by weight of iron (Fe) bound to the exogenous heme-containing protein.
8 . The hybrid meat substitute product of claim 1 , wherein less than 20% of the exogenous heme-containing protein in the hybrid meat substitute product is comprised within the cultured animal cells.
9 . The hybrid meat substitute product of claim 1 , comprising between 1-20% the cultured animal cells by weight.
10 . The hybrid meat substitute product of claim 1 , comprising between 2-10% the cultured animal cells by weight.
11 . The hybrid meat substitute product of claim 1 , wherein the cultured animal cells are bovine cells.
12 . The hybrid meat substitute product of claim 1 , wherein the cultured animal cells comprise, or are derived from, skeletal muscle cells, myoblasts, myogenic cells, fibroblasts, mesenchymal stem cells, endothelial cells, adipose progenitor cells, preadipocytes, or cardiomyocytes.
13 . The hybrid meat substitute product of claim 1 , wherein the cultured animal cells are myoblasts.
14 . The hybrid meat substitute product of claim 1 , wherein the cultured animal cells are fibroblasts.
15 . The hybrid meat substitute product of claim 1 , wherein the cultured animal cells are not in a meat structure.
16 . The hybrid meat substitute product of claim 1 , comprising:
d) animal fat.
17 . The hybrid meat substitute product of claim 16 , comprising between 0.1-30% the animal fat by weight.
18 . A method of producing a hybrid substitute meat product, comprising mixing cultured animal cells and an exogenous heme-containing protein with a plant-based meat dough.
19 . The method of claim 18 , wherein the exogenous heme-containing protein is provided as an isolated ingredient.
20 . The method of claim 18 , wherein the cultured animal cells is at least 1% by weight and the exogenous heme-containing protein is at least 0.50% by weight in the hybrid substitute meat product.Join the waitlist — get patent alerts
Track US2024016185A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.